"New taxes and government price controls on prescription drugs will not address the skyrocketing costs of the American health care system," said
"Again, I'm very disappointed in the partisan process Speaker Pelosi has chosen on a critical issue like health care reform,"
Provisions of H.R. 965, the CREATES Act, which is bipartisan legislation that was signed into law last year, lowers the cost of prescription drugs by regulating anti-competitive practices of drug manufacturers that block the entry of low-cost generic drugs into the marketplace.
And last year,
H.R. 1425 does not address the underlying issue with American health care - the skyrocketing cost of care. Rather than working to lower the cost of care, H.R. 1425 merely shifts the cost of care around to taxpayers and manufacturers of prescription drugs that treat and cure diseases.
H.R. 1425 is funded through provisions that were included in H.R. 3, which levies new taxes and establishes government price controls on manufacturers of prescription drugs. Last December, the
You can find a one-pager on H.R. 1425 here https://rodneydavis.house.gov/UploadedFiles/H.R._1425_PPACA_Expansion_One-Pager.pdf.